Press ReleaseKaiseraugst (Switzerland), Maastricht (Netherlands), October 30, 2025 dsm-firmenich Q3 2025 trading update Management Report Q3 2025 highlights Solid growth and strong step up in Adjusted EBITDA on a comparable basis1Advancing well on 2025 strategic planAnimal Nutrition & Health (‘ANH’) exit process ongoingFY 2025 outlook updated for foreign exchange and ANH-related vitamin volatility: Adjusted EBITDA of around €2.3 billion Key figures in € millionsQ3 YTD 2025Q3 YTD 2024% ChangeQ3 2025Q3 202 ...